For tenosynovitis, ACPA+, RF+, anti-CarP+ patients had higher scores than ACPA-, RF-, anti-CarP- patients (median 4.5 vs. 1.0, p < 0.001), and ACPA+, RF+, anti-CarP+ patients had higher scores than ACPA+, RF+, anti-CarP- patients (median 4.5 vs. 3.5 p = 0.039). The gene discussed is PRTN3; the disease is tenosynovitis.